zm 241385 has been researched along with psb603 in 6 studies
| Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (psb603) | Trials (psb603) | Recent Studies (post-2010) (psb603) |
|---|---|---|---|---|---|
| 401 | 3 | 124 | 14 | 0 | 13 |
| Protein | Taxonomy | zm 241385 (IC50) | psb603 (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0005 | |
| Adenosine receptor A3 | Rattus norvegicus (Norway rat) | 0.0007 | |
| Adenosine receptor A2b | Homo sapiens (human) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| French, SW; Khachatoorian, R; Micewicz, ED; Ruchala, P | 1 |
| Behrenswerth, A; Fiene, A; Gollos, S; Heisig, F; Karcz, T; Kieć-Kononowicz, K; Köse, M; Müller, CE; Namasivayam, V | 1 |
| Alispahic, B; Åqvist, J; Azuaje, J; Brea, J; Caamaño, O; Crespo, A; El Maatougui, A; Fernandez-Masaguer, C; Freire-Garabal, M; García-Mera, X; Garcia-Santiago, C; Gioé, C; Gutiérrez-de-Terán, H; Jespers, W; Loza, MI; Majellaro, M; Mallo-Abreu, A; Novio, S; Núñez, MJ; Prieto-Díaz, R; Rodríguez-García, C; Sardina, JF; Sotelo, E; Stefanachi, A | 1 |
| Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G | 1 |
| Christopoulos, A; Gregory, KJ; May, LT; Tan, CY; Vecchio, EA; White, PJ | 1 |
| Adam, RM; Chung, YG; Cristofaro, V; Doyle, C; Lukianov, SN; Sack, BS; Schäfer, M; Sullivan, MP | 1 |
1 review(s) available for zm 241385 and psb603
| Article | Year |
|---|---|
Adenosine receptor antagonists: Recent advances and therapeutic perspective.
Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship | 2022 |
5 other study(ies) available for zm 241385 and psb603
| Article | Year |
|---|---|
Identification of novel small-molecule inhibitors of Zika virus infection.
Topics: A549 Cells; Antiviral Agents; Cell Survival; Dose-Response Relationship, Drug; Humans; Molecular Structure; Small Molecule Libraries; Structure-Activity Relationship; Zika Virus; Zika Virus Infection | 2018 |
Fluorescent-Labeled Selective Adenosine A
Topics: Adenosine A2 Receptor Antagonists; Animals; Binding, Competitive; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Flow Cytometry; Fluorescent Dyes; Humans; Mice; Models, Molecular; Molecular Structure; Protein Binding; Protein Conformation; Radioligand Assay; Rats; Receptor, Adenosine A2B | 2018 |
3,4-Dihydropyrimidin-2(1
Topics: Adenosine A2 Receptor Antagonists; Animals; CHO Cells; Cricetulus; Cyclic AMP; HEK293 Cells; HeLa Cells; Humans; Models, Molecular; Neoplasm Metastasis; Pyrimidines; Radioligand Assay; Receptor, Adenosine A2B; Stereoisomerism; Structure-Activity Relationship | 2021 |
Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Deaminase; Animals; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Drug Design; Humans; Inositol Phosphates; Ligands; Male; MAP Kinase Signaling System; Prostatic Neoplasms; Receptor, Adenosine A2B; Signal Transduction; Sulfonamides; Triazines; Triazoles; Xanthines | 2016 |
Inosine attenuates spontaneous activity in the rat neurogenic bladder through an A
Topics: Adenosine A2 Receptor Antagonists; Animals; Disease Models, Animal; Humans; Inosine; Potassium Channels; Rats; Receptor, Adenosine A2A; Spinal Cord Injuries; Sulfonamides; Triazines; Triazoles; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Xanthines | 2017 |